PL2222293T3 - Medyczne zastosowanie 3-(2,2,2-trimetylohydrazyno) propionianu wodorofumaranu i diwodorofosforanu - Google Patents
Medyczne zastosowanie 3-(2,2,2-trimetylohydrazyno) propionianu wodorofumaranu i diwodorofosforanuInfo
- Publication number
- PL2222293T3 PL2222293T3 PL08857026T PL08857026T PL2222293T3 PL 2222293 T3 PL2222293 T3 PL 2222293T3 PL 08857026 T PL08857026 T PL 08857026T PL 08857026 T PL08857026 T PL 08857026T PL 2222293 T3 PL2222293 T3 PL 2222293T3
- Authority
- PL
- Poland
- Prior art keywords
- trimethylhydrazinium
- dihydrogen phosphate
- medical use
- hydrogen fumarate
- propionate hydrogen
- Prior art date
Links
- DSMFFOSDNKPHJP-TYYBGVCCSA-N (e)-but-2-enedioic acid;propanoic acid Chemical compound CCC(O)=O.OC(=O)\C=C\C(O)=O DSMFFOSDNKPHJP-TYYBGVCCSA-N 0.000 title 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07122273 | 2007-12-04 | ||
| EP07122272 | 2007-12-04 | ||
| PCT/EP2008/066711 WO2009071585A1 (en) | 2007-12-04 | 2008-12-03 | Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate |
| EP08857026A EP2222293B1 (en) | 2007-12-04 | 2008-12-03 | Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2222293T3 true PL2222293T3 (pl) | 2012-01-31 |
Family
ID=40481525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08857026T PL2222293T3 (pl) | 2007-12-04 | 2008-12-03 | Medyczne zastosowanie 3-(2,2,2-trimetylohydrazyno) propionianu wodorofumaranu i diwodorofosforanu |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20100234459A1 (pl) |
| EP (1) | EP2222293B1 (pl) |
| JP (1) | JP2011505408A (pl) |
| KR (1) | KR20100084688A (pl) |
| CN (1) | CN101951898B (pl) |
| AR (1) | AR069521A1 (pl) |
| AT (1) | ATE518536T1 (pl) |
| AU (1) | AU2008333262A1 (pl) |
| BR (1) | BRPI0819057A2 (pl) |
| CA (1) | CA2706354C (pl) |
| CL (1) | CL2008003551A1 (pl) |
| CO (1) | CO6280477A2 (pl) |
| CY (1) | CY1112336T1 (pl) |
| DK (1) | DK2222293T3 (pl) |
| DO (1) | DOP2010000163A (pl) |
| EA (1) | EA019424B1 (pl) |
| GE (1) | GEP20125673B (pl) |
| HR (1) | HRP20110744T1 (pl) |
| IL (1) | IL205961A0 (pl) |
| MA (1) | MA31993B1 (pl) |
| MX (1) | MX2010006255A (pl) |
| MY (1) | MY150508A (pl) |
| PA (1) | PA8805901A1 (pl) |
| PE (1) | PE20091037A1 (pl) |
| PL (1) | PL2222293T3 (pl) |
| PT (1) | PT2222293E (pl) |
| RS (1) | RS51992B (pl) |
| SI (1) | SI2222293T1 (pl) |
| TN (1) | TN2010000250A1 (pl) |
| TW (1) | TW200930356A (pl) |
| WO (1) | WO2009071585A1 (pl) |
| ZA (1) | ZA201003641B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2425835A1 (en) * | 2010-08-18 | 2012-03-07 | Grindeks, a joint stock company | A new medical use of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate and natural flavonoid derivatives |
| TWI487524B (zh) * | 2010-12-03 | 2015-06-11 | Tetra Sia | 菸鹼酸和米曲肼之新穎治療組合 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06000955A (es) * | 2003-08-04 | 2006-03-30 | Grindeks Jsc | Sales de meldonio, metodo para su preparacion y composiciones farmaceuticas basadas en ellas. |
-
2008
- 2008-11-26 TW TW097145676A patent/TW200930356A/zh unknown
- 2008-11-27 PE PE2008001984A patent/PE20091037A1/es not_active Application Discontinuation
- 2008-11-28 PA PA20088805901A patent/PA8805901A1/es unknown
- 2008-11-28 CL CL2008003551A patent/CL2008003551A1/es unknown
- 2008-12-02 AR ARP080105237A patent/AR069521A1/es unknown
- 2008-12-03 JP JP2010536438A patent/JP2011505408A/ja not_active Ceased
- 2008-12-03 BR BRPI0819057 patent/BRPI0819057A2/pt not_active IP Right Cessation
- 2008-12-03 US US12/734,779 patent/US20100234459A1/en not_active Abandoned
- 2008-12-03 GE GEAP200811832A patent/GEP20125673B/en unknown
- 2008-12-03 PL PL08857026T patent/PL2222293T3/pl unknown
- 2008-12-03 EA EA201000738A patent/EA019424B1/ru not_active IP Right Cessation
- 2008-12-03 DK DK08857026.2T patent/DK2222293T3/da active
- 2008-12-03 KR KR1020107012218A patent/KR20100084688A/ko not_active Ceased
- 2008-12-03 CN CN2008801194045A patent/CN101951898B/zh not_active Expired - Fee Related
- 2008-12-03 AU AU2008333262A patent/AU2008333262A1/en not_active Abandoned
- 2008-12-03 RS RS20110470A patent/RS51992B/sr unknown
- 2008-12-03 CA CA2706354A patent/CA2706354C/en not_active Expired - Fee Related
- 2008-12-03 WO PCT/EP2008/066711 patent/WO2009071585A1/en not_active Ceased
- 2008-12-03 AT AT08857026T patent/ATE518536T1/de active
- 2008-12-03 HR HR20110744T patent/HRP20110744T1/hr unknown
- 2008-12-03 MX MX2010006255A patent/MX2010006255A/es not_active Application Discontinuation
- 2008-12-03 MY MYPI20102603 patent/MY150508A/en unknown
- 2008-12-03 SI SI200830410T patent/SI2222293T1/sl unknown
- 2008-12-03 PT PT08857026T patent/PT2222293E/pt unknown
- 2008-12-03 EP EP08857026A patent/EP2222293B1/en active Active
-
2010
- 2010-05-21 ZA ZA2010/03641A patent/ZA201003641B/en unknown
- 2010-05-25 IL IL205961A patent/IL205961A0/en unknown
- 2010-06-01 TN TN2010000250A patent/TN2010000250A1/fr unknown
- 2010-06-02 DO DO2010000163A patent/DOP2010000163A/es unknown
- 2010-06-03 CO CO10067244A patent/CO6280477A2/es not_active Application Discontinuation
- 2010-07-01 MA MA32978A patent/MA31993B1/fr unknown
-
2011
- 2011-10-25 CY CY20111101004T patent/CY1112336T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2076172A4 (en) | USE OF COHERENT RAMAN PROCEDURES FOR MEDICAL DIAGNOSTIC AND THERAPEUTIC PURPOSES AND CALIBRATION METHOD THEREFOR | |
| IL198184A0 (en) | Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue | |
| PL2104682T3 (pl) | Diagnostyka i leczenie choroby Alzheimera i innych chorób neurodegeneracyjnych | |
| IL210856A0 (en) | Combination therapy for the treatment of diabetes and related conditions | |
| EP2097012A4 (en) | DEVICES AND METHOD FOR TREATING HEART FAILURE | |
| EP1917065A4 (en) | ADJUSTMENT MECHANISM FOR ELECTRICAL MEDICAL DEVICES AND APPLICATION METHODS | |
| IL216967B (en) | The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases | |
| IL201479A (en) | Use of tapentadol for the preparation of pain medication | |
| IL193747A0 (en) | New therapeutic combinations for the treatment of depression | |
| GB0610867D0 (en) | Treatment of pain | |
| EP2251060A4 (en) | VALVE BODY, VALVE BODY MANUFACTURING METHOD, AND MEDICAL INSTRUMENT | |
| PL2328417T3 (pl) | Związki, kompozycje i sposoby leczenia chorób beta-amyloidowych i synukleinopatii | |
| ZA200806808B (en) | Treatment of stressed patients | |
| EP2091480A4 (en) | SYSTEM FOR THE TREATMENT OF HEART TISSUE | |
| EP2320939A4 (en) | TISSUE CALLICLE FOR THE TREATMENT OF PARKINSON DISEASE | |
| IL213703A (en) | Compounds for the treatment of pain and other diseases | |
| EP2255835A4 (en) | MEDICAL INSTRUMENT, MEDICAL MATERIAL AND METHOD FOR PRODUCING THE MEDICAL INSTRUMENT AND MEDICAL MATERIAL | |
| IL192933A0 (en) | Benzoisoindole derivatives for the treatment of pain | |
| IL205961A0 (en) | Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate | |
| TN2010000249A1 (en) | New medical use of 3-(2,2,2-trimethylhydrazinium ) propionate salts | |
| IL207668A0 (en) | Beloxepin, its enantiomers, and analogs thereof for the treatment of pain | |
| WO2009074498A8 (en) | Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate | |
| PL2307380T3 (pl) | Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego | |
| UA100129C2 (ru) | Применение гидрофумарата и дигидрофосфата 3-(2,2,2-триметилгидразиния) пропионата для лечения или профилактики атеросклероза | |
| IL197291A0 (en) | Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns |